Original Research
Published on 28 Apr 2022
The Diagnostic Significance of CXCL13 in M2 Tumor Immune Microenvironment of Human Astrocytoma
Pathology and Oncology Research
doi 10.3389/pore.2022.1610230
Type at least 3 characters
2,920 articles
Original Research
Published on 27 Apr 2022
High Neutrophil-To-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) Are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only Metastasis of Rectal Cancer
Pathology and Oncology Research
doi 10.3389/pore.2022.1610315
Original Research
Published on 27 Apr 2022
Pretreatment Systemic Immune-Inflammation Index Can Predict Response to Neoadjuvant Chemotherapy in Cervical Cancer at Stages IB2-IIB
Pathology and Oncology Research
doi 10.3389/pore.2022.1610294
Brief Research Report
Published on 22 Apr 2022
HLA Class I Downregulation in Progressing Metastases of Melanoma Patients Treated With Ipilimumab
Pathology and Oncology Research
doi 10.3389/pore.2022.1610297
Letter to the Editor
Published on 22 Apr 2022
Blocking the Metabolic Switch Toward Cytosolic 1C Flux: A Novel Therapeutic Approach for Tumors With Low SLC19A1 Expression
Pathology and Oncology Research
doi 10.3389/pore.2022.1610337
Original Research
Published on 20 Apr 2022
Diagnostic Value of Six Tumor Markers for Malignant Pleural Effusion in 1,230 Patients: A Single-Center Retrospective Study
Pathology and Oncology Research
doi 10.3389/pore.2022.1610280
Original Research
Published on 19 Apr 2022
Pathological Changes and Expression of JAK-STAT Signaling Pathway Hallmark Proteins in Rat Retinas at Different Time Points After Retinal Ischemia Reperfusion Injury
Pathology and Oncology Research
doi 10.3389/pore.2022.1610385
Original Research
Published on 12 Apr 2022
Methodological Challenges of Digital PCR Detection of the Histone H3 K27M Somatic Variant in Cerebrospinal Fluid
Pathology and Oncology Research
doi 10.3389/pore.2022.1610024
Brief Research Report
Published on 11 Apr 2022
PD-L1 Testing in Urothelial Carcinoma: Analysis of a Series of 1401 Cases Using Both the 22C3 and SP142 Assays
Pathology and Oncology Research
doi 10.3389/pore.2022.1610260
Brief Research Report
Published on 05 Apr 2022
Co-Detection of VEGF-A and Its Regulator, microRNA-181a, May Indicate Central Nervous System Involvement in Pediatric Leukemia
Pathology and Oncology Research
doi 10.3389/pore.2022.1610096
Brief Research Report
Published on 31 Mar 2022
Clinical Course of COVID-19 Disease in Children Treated With Neoplastic Diseases in Hungary
Pathology and Oncology Research
doi 10.3389/pore.2022.1610261
Case Report
Published on 23 Mar 2022
Case Report: A Case of Gallbladder Carcinosarcoma With Osteoclast-like Multinucleated Giant Cells that Was Associated With RANK‐RANKL Signaling
Pathology and Oncology Research
doi 10.3389/pore.2022.1610134
Original Research
Published on 22 Mar 2022
In Situ Analysis of mTORC1/C2 and Metabolism-Related Proteins in Pediatric Osteosarcoma
Pathology and Oncology Research
doi 10.3389/pore.2022.1610231
Brief Research Report
Published on 21 Mar 2022
A Novel Prognostic Factor TIPE2 in Bladder Cancer
Pathology and Oncology Research
doi 10.3389/pore.2022.1610282
Original Research
Published on 18 Mar 2022
RING-Finger Protein 6 promotes Drug Resistance in Retinoblastoma via JAK2/STAT3 Signaling Pathway
Pathology and Oncology Research
doi 10.3389/pore.2022.1610273
Original Research
Published on 17 Mar 2022
Circular RNAs as Diagnostic and Prognostic Indicators of Colorectal Cancer: A Pooled Analysis of Individual Studies
Pathology and Oncology Research
doi 10.3389/pore.2022.1610037